作者搜索結果

1

COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION

COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION

由 D. V. Nebieridze
出版 2016-01-01

獲取全文

Artigo

2

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

由 D. V. Nebieridze
出版 2015-12-01

獲取全文

Artigo

3

CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS

CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS

由 D. V. Nebieridze
出版 2015-12-01

獲取全文

Artigo

4

Hyperuricemia a New Cardiovascular Risk Factor

Hyperuricemia a New Cardiovascular Risk Factor

由 D. V. Nebieridze
出版 2020-03-01

獲取全文

Artigo

5

Topical issues of beta-blockers use in various clinical situations

Topical issues of beta-blockers use in various clinical situations

由 D. V. Nebieridze
出版 2018-07-01

獲取全文

Artigo

6

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS

由 D. V. Nebieridze
出版 2002-02-01

獲取全文

Artigo

7

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

由 D. V. Nebieridze
出版 2015-12-01

獲取全文

Artigo

8

Topical questions of beta-blockers application in clinical practice

Topical questions of beta-blockers application in clinical practice

由 D V Nebieridze
出版 2014-12-01

獲取全文

Artigo

9

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?

由 D. V. Nebieridze, A. S. Safarian
出版 2016-01-01

獲取全文

Artigo

10

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

由 D. V. Nebieridze, T. V. Kamyshova
出版 2015-12-01

獲取全文

Artigo

11

Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II

Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II

由 A. S. Safaryan, D. V. Nebieridze
出版 2021-10-01

獲取全文

Artigo

12

New potential of ACE inhibitors in clinical practice

New potential of ACE inhibitors in clinical practice

由 D. V. Nebieridze, A. S. Safaryan
出版 2010-10-01

獲取全文

Artigo

13

High-risk patients: modern treatment strategy

High-risk patients: modern treatment strategy

由 D. V. Nebieridze, A. Meliya
出版 2010-12-01

獲取全文

Artigo

14

Place of imidazoline receptor agonists in the treatment of hypertension

Place of imidazoline receptor agonists in the treatment of hypertension

由 D. V. Nebieridze, A. S. Safaryan
出版 2022-01-01

獲取全文

Artigo

15

Imidazoline receptor agonists: more than blood pressure reduction?

Imidazoline receptor agonists: more than blood pressure reduction?

由 D. V. Nebieridze, S. V. Nedogoda
出版 2006-04-01

獲取全文

Artigo

16

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

由 D. V. Nebieridze, T. V. Kamyshova
出版 2015-12-01

獲取全文

Artigo

17

PREVALENCE OF HYPERURICEMIA AMONG PATIENTS WITH METABOLIC SYNDROME: RESULTS OF THE STUDY IN REAL CLINICAL PRACTICE

PREVALENCE OF HYPERURICEMIA AMONG PATIENTS WITH METABOLIC SYNDROME: RESULTS OF THE STUDY IN REAL CLINICAL PRACTICE

由 D. V. Nebieridze, N. V. Dolgushina
出版 2017-12-01

獲取全文

Artigo

18

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2)

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2)

由 A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze
出版 2020-07-01

獲取全文

Artigo

19

IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS?

IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS?

由 A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
出版 2017-11-01

獲取全文

Artigo

20

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues

由 N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
出版 2019-01-01

獲取全文

Artigo